FibroGen Odds of Future Stock Price Finishing Over 9.71
| FGENDelisted Stock | USD 9.71 0.48 5.20% |
FibroGen |
FibroGen Target Price Odds to finish over 9.71
The tendency of FibroGen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.71 | 90 days | 9.71 | about 48.65 |
Based on a normal probability distribution, the odds of FibroGen to move above the current price in 90 days from now is about 48.65 (This FibroGen probability density function shows the probability of FibroGen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days FibroGen has a beta of -0.0111. This usually indicates as returns on the benchmark increase, returns on holding FibroGen are expected to decrease at a much lower rate. During a bear market, however, FibroGen is likely to outperform the market. Additionally FibroGen has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. FibroGen Price Density |
| Price |
Predictive Modules for FibroGen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as FibroGen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FibroGen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
FibroGen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. FibroGen is not an exception. The market had few large corrections towards the FibroGen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold FibroGen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of FibroGen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | -0.01 | |
σ | Overall volatility | 1.18 | |
Ir | Information ratio | -0.08 |
FibroGen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of FibroGen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for FibroGen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| FibroGen is now traded under the symbol KYNB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| FibroGen is not yet fully synchronised with the market data | |
| FibroGen generated a negative expected return over the last 90 days | |
| FibroGen has high historical volatility and very poor performance | |
| FibroGen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 29.62 M. Net Loss for the year was (47.58 M) with loss before overhead, payroll, taxes, and interest of (30.35 M). | |
| FibroGen currently holds about 438.13 M in cash with (138 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.67. | |
| Latest headline from thelincolnianonline.com: BioAtla, Inc. Short Interest Down 29.9 percent in December |
FibroGen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of FibroGen Stock often depends not only on the future outlook of the current and potential FibroGen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. FibroGen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 100 M | |
| Cash And Short Term Investments | 50.5 M |
FibroGen Technical Analysis
FibroGen's future price can be derived by breaking down and analyzing its technical indicators over time. FibroGen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of FibroGen. In general, you should focus on analyzing FibroGen Stock price patterns and their correlations with different microeconomic environments and drivers.
FibroGen Predictive Forecast Models
FibroGen's time-series forecasting models is one of many FibroGen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary FibroGen's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about FibroGen
Checking the ongoing alerts about FibroGen for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for FibroGen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| FibroGen is now traded under the symbol KYNB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| FibroGen is not yet fully synchronised with the market data | |
| FibroGen generated a negative expected return over the last 90 days | |
| FibroGen has high historical volatility and very poor performance | |
| FibroGen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 29.62 M. Net Loss for the year was (47.58 M) with loss before overhead, payroll, taxes, and interest of (30.35 M). | |
| FibroGen currently holds about 438.13 M in cash with (138 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.67. | |
| Latest headline from thelincolnianonline.com: BioAtla, Inc. Short Interest Down 29.9 percent in December |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |